SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL455-MS]

GTX635712
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL455-MS]
- Delivery Days Customer9
- Antibody SpecificityThis antibody detects both SARS-CoV nucleocapsid and SARS-CoV-2 nucleocapsid proteins. Our internal testing indicates no cross-reactivity with MERS-CoV nucleocapsid protein.
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHL455-MS
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- HostMouse
- IsotypeIgG1
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection. Liu W et al., 2021 May 24, J VirolRead more